Egis History

The most important milestones in the history of Egis:

1913
1913
Establishment of the company
1926
1926
Presence at the International Humanitarian Exhibition
1933
1933
Opening our first research laboratory in Budapest
1937
1937
Ronin: first heterocyclic sulfonamide drug
1940
1940
Construction and modernization
1950
1950
EGYT (predecessor of Egis) established
1954
1954
Expanding
1973
1973
New production plant in Körmend
1985
1985
Name changed to Egis
1994
1994
Egis shares were introduced to the Hungarian Stock Exchange
1994
1994
Establishment of Egis Pharmaceuticals LTD polish division - EGIS Polska Sp. z o.o.
1995
1995
Servier aquires 51% of Egis
1997
1997
Extending the offer of drugs EGIS Polska Sp. z o.o.
2002
2002
The development of EGIS Polska Sp. z o.o.
2006
2006
New strategy
2009
2009
New tablet production plant
2012
2012
Egis Polska Sp. z o.o. moves to a new office
2012
2012
EGIS Polska introduces a combination of ramipril and amlodipine (Egiramlon)
2013
2013
Market Launch of Biosimilar Products
2013
2013
The portfolio of EGIS Polska expends by the family of DIP ointments
2015
2015
A market leader biosimilar product
2015
2015
Purchase of rights to the Biovital brand
2015
2015
EGIS Polska introduces a combination of rozuwastatyna and ezetymib (Rosulip Plus)
2018
2018
A market leader biosimilar product, first successful acquisition
2019
2019
New guidelines for Milurit
2019
2019
25th anniversary of EGIS Polska Sp. z o.o.
WarningYour browser is out of date. Please, use an updated version! Chrome || Firefox